NHI Quote, Financials, Valuation and Earnings

Host Hotels & Resorts has a net margin of 34.41% compared to National Health Investors's net margin of 6.22%. National Health Investors's return on equity of 10.01% beat Host Hotels & Resorts's return on equity of 10.4%.

National Health Investors has a consensus price target of --, signalling upside risk potential of 19.01%. On the other hand Host Hotels & Resorts has an analysts' consensus of $20.47 which suggests that it could grow by 12.36%. Given that National Health Investors has higher upside potential than Host Hotels & Resorts, analysts believe National Health Investors is more attractive than Host Hotels & Resorts.

National Health Investors has a beta of 1.043, which suggesting that the stock is 4.334% more volatile than S&P 500. In comparison Host Hotels & Resorts has a beta of 1.321, suggesting its more volatile than the S&P 500 by 32.067%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 5.19%. Host Hotels & Resorts offers a yield of 4.39% to investors and pays a quarterly dividend of $0.20 per share. National Health Investors pays 115.17% of its earnings as a dividend. Host Hotels & Resorts pays out 73.92% of its earnings as a dividend. Host Hotels & Resorts's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but National Health Investors's is not.

National Health Investors quarterly revenues are $82.9M, which are smaller than Host Hotels & Resorts quarterly revenues of $1.3B. National Health Investors's net income of $28.5M is lower than Host Hotels & Resorts's net income of $82M. Notably, National Health Investors's price-to-earnings ratio is 23.84x while Host Hotels & Resorts's PE ratio is 17.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.20x versus 2.31x for Host Hotels & Resorts. Usually stocks with elevated PS ratios are considered overvalued.

Prologis has a net margin of 34.41% compared to National Health Investors's net margin of 49.39%. National Health Investors's return on equity of 10.01% beat Prologis's return on equity of 5.33%.

National Health Investors has a consensus price target of --, signalling upside risk potential of 19.01%. On the other hand Prologis has an analysts' consensus of $130.33 which suggests that it could grow by 24.48%. Given that Prologis has higher upside potential than National Health Investors, analysts believe Prologis is more attractive than National Health Investors.

National Health Investors has a beta of 1.043, which suggesting that the stock is 4.334% more volatile than S&P 500. In comparison Prologis has a beta of 1.073, suggesting its more volatile than the S&P 500 by 7.27%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 5.19%. Prologis offers a yield of 3.67% to investors and pays a quarterly dividend of $0.96 per share. National Health Investors pays 115.17% of its earnings as a dividend. Prologis pays out 105.54% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $82.9M, which are smaller than Prologis quarterly revenues of $2B. National Health Investors's net income of $28.5M is lower than Prologis's net income of $1B. Notably, National Health Investors's price-to-earnings ratio is 23.84x while Prologis's PE ratio is 31.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.20x versus 12.65x for Prologis. Usually stocks with elevated PS ratios are considered overvalued.

Regency Centers has a net margin of 34.41% compared to National Health Investors's net margin of 28.17%. National Health Investors's return on equity of 10.01% beat Regency Centers's return on equity of 5.68%.

National Health Investors has a consensus price target of --, signalling upside risk potential of 19.01%. On the other hand Regency Centers has an analysts' consensus of $79.21 which suggests that it could grow by 6.32%. Given that National Health Investors has higher upside potential than Regency Centers, analysts believe National Health Investors is more attractive than Regency Centers.

National Health Investors has a beta of 1.043, which suggesting that the stock is 4.334% more volatile than S&P 500. In comparison Regency Centers has a beta of 1.221, suggesting its more volatile than the S&P 500 by 22.13%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 5.19%. Regency Centers offers a yield of 3.64% to investors and pays a quarterly dividend of $0.71 per share. National Health Investors pays 115.17% of its earnings as a dividend. Regency Centers pays out 125.21% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $82.9M, which are smaller than Regency Centers quarterly revenues of $360.3M. National Health Investors's net income of $28.5M is lower than Regency Centers's net income of $101.5M. Notably, National Health Investors's price-to-earnings ratio is 23.84x while Regency Centers's PE ratio is 35.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.20x versus 9.50x for Regency Centers. Usually stocks with elevated PS ratios are considered overvalued.

Welltower has a net margin of 34.41% compared to National Health Investors's net margin of 22.37%. National Health Investors's return on equity of 10.01% beat Welltower's return on equity of 3.28%.

National Health Investors has a consensus price target of --, signalling upside risk potential of 19.01%. On the other hand Welltower has an analysts' consensus of $144.11 which suggests that it could grow by 13.84%. Given that National Health Investors has higher upside potential than Welltower, analysts believe National Health Investors is more attractive than Welltower.

National Health Investors has a beta of 1.043, which suggesting that the stock is 4.334% more volatile than S&P 500. In comparison Welltower has a beta of 1.206, suggesting its more volatile than the S&P 500 by 20.563%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 5.19%. Welltower offers a yield of 2.02% to investors and pays a quarterly dividend of $0.67 per share. National Health Investors pays 115.17% of its earnings as a dividend. Welltower pays out 370.66% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $82.9M, which are smaller than Welltower quarterly revenues of $2B. National Health Investors's net income of $28.5M is lower than Welltower's net income of $449.8M. Notably, National Health Investors's price-to-earnings ratio is 23.84x while Welltower's PE ratio is 83.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.20x versus 10.13x for Welltower. Usually stocks with elevated PS ratios are considered overvalued.